Clinical Trial Update: Randomized Phase II Study of FOLFOX Versus FOLFIRI.3 in Gemcitabine-refractory Pancreatic Cancer [Phase 2]

View source ↗

Summary

This document reports a randomized Phase II trial comparing FOLFOX versus FOLFIRI.3 in gemcitabine-refractory pancreatic cancer, and notes that the study has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• FOLFIRI.3 (folinic acid + fluorouracil + irinotecan)
• FOLFOX

Snippet

Sponsor: Asan Medical Center | Conditions: Metastatic Pancreatic Cancer | Phase 2 | Status: COMPLETED